P

PerkinElmer Inc
LSE:0KHE

Watchlist Manager
PerkinElmer Inc
LSE:0KHE
Watchlist
Price: 97.84 USD 0.12%
Market Cap: 1.1T USD

Intrinsic Value

The intrinsic value of one 0KHE stock under the Base Case scenario is 1.8 USD. Compared to the current market price of 97.84 USD, PerkinElmer Inc is Overvalued by 98%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0KHE Intrinsic Value
1.8 USD
Overvaluation 98%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
PerkinElmer Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about 0KHE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0KHE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PerkinElmer Inc.

Explain Valuation
Compare 0KHE to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

PerkinElmer’s diagnostic segment saw extraordinary pandemic-driven revenue, and a sustained decline in COVID-19 testing presents a risk that the company won’t be able to fully replace that high-margin business with other offerings, threatening overall profit growth.

Recent acquisitions, including those in the applied genomics and proteomics fields, could lead to integration challenges. Failure to harmonize product lines and maintain service quality could dilute PerkinElmer’s brand reputation and create expensive inefficiencies in its supply chain.

Heavier competition from well-capitalized peers, such as Danaher and Thermo Fisher Scientific, may intensify pricing pressure and slow the company’s expansion in life science instrumentation, particularly in emerging markets where PerkinElmer is attempting to capture new share.

Bull Theses

PerkinElmer’s strong foothold in highly specialized analytical and detection instruments differentiates it in niche markets, driving repeat business and enabling premium pricing, particularly in the pharmaceutical and biotech sectors.

Ongoing investment in research and development, especially in advanced technologies such as next-generation sequencing and high-throughput screening, supports long-term product innovation and improves PerkinElmer’s competitive edge for future market opportunities.

The firm’s growth in food and environmental testing solutions continues to open new revenue channels, leveraging global demand for more sophisticated testing protocols and aligning with regulatory trends favoring stricter safety standards.

Show More Less
How do you feel about 0KHE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PerkinElmer Inc

Current Assets 2.1B
Cash & Short-Term Investments 931.4m
Receivables 680.3m
Other Current Assets 532.1m
Non-Current Assets 10B
PP&E 668.2m
Intangibles 9B
Other Non-Current Assets 300.4m
Current Liabilities 1.2B
Accounts Payable 175.8m
Accrued Liabilities 463.1m
Other Current Liabilities 583.8m
Non-Current Liabilities 3.5B
Long-Term Debt 2.6B
Other Non-Current Liabilities 909.6m
Efficiency

Free Cash Flow Analysis
PerkinElmer Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PerkinElmer Inc

Revenue
2.8B USD
Cost of Revenue
-1.3B USD
Gross Profit
1.6B USD
Operating Expenses
-1.2B USD
Operating Income
366.5m USD
Other Expenses
-129m USD
Net Income
237.5m USD
Fundamental Scores

0KHE Profitability Score
Profitability Due Diligence

PerkinElmer Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Healthy Operating Margin
47/100
Profitability
Score

PerkinElmer Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.

0KHE Solvency Score
Solvency Due Diligence

PerkinElmer Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

PerkinElmer Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

0KHE Price Targets Summary
PerkinElmer Inc

Wall Street analysts forecast 0KHE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0KHE is 115.51 USD with a low forecast of 86.34 USD and a high forecast of 142.56 USD.

Lowest
Price Target
86.34 USD
12% Downside
Average
Price Target
115.51 USD
18% Upside
Highest
Price Target
142.56 USD
46% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 0KHE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 0KHE stock?

The intrinsic value of one 0KHE stock under the Base Case scenario is 1.8 USD.

Is 0KHE stock undervalued or overvalued?

Compared to the current market price of 97.84 USD, PerkinElmer Inc is Overvalued by 98%.

Back to Top